• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    Alkermes plc (ALKS)

    -NasdaqGS
    63.15 Up 1.98(3.24%) Aug 28, 4:00PM EDT
    |After Hours : 62.09 Down 1.06 (1.67%) Aug 28, 4:10PM EDT
    Add to Portfolio
    Prev Close:61.17
    Open:60.96
    Bid:N/A
    Ask:65.00 x 1000
    1y Target Est:70.60
    Beta:1.22362
    Next Earnings Date:N/A
    Day's Range:60.49 - 63.28
    52wk Range:38.49 - 75.17
    Volume:812,108
    Avg Vol (3m):950,877
    Market Cap:9.43B
    P/E (ttm):N/A
    EPS (ttm):-0.59
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALKSUp 3.24%9.43B
    GSKUp 0.10%99.70B
    ABTUp 0.83%68.59B
    LLYDown 0.66%88.10B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14.11
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.40
    Quarterly EPS Est (Sep-15) :-0.20
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-4.37

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alkermes Public Limited Company, an integrated biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in various therapeutic areas. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback